Kizoo Technology Capital

Reservoir Neuroscience, Inc. is a biopharmaceutical company focused on developing innovative therapeutics aimed at repairing the blood-brain barrier and restoring vascular function in the brain. Founded in 2019 and located in Emeryville, California, the company targets age-related cognitive impairments and neurological disorders such as Alzheimer's disease. Its therapeutics are designed to address dysfunctional blood vessels in the brain, thereby improving disease outcomes for patients and enhancing their access to effective medical interventions.

Cellvie specializes in the development of cell-derived medicines that focus on mitochondrial transplantation to address various medical conditions related to mitochondrial dysfunction. Recognizing the critical role of mitochondria in energy production and cellular processes, the company employs proprietary techniques to prepare and deliver viable mitochondria directly into compromised cells. This innovative approach aims to restore energy metabolism in cells affected by conditions such as heart disease, stroke, diabetes, Parkinson's, and Alzheimer's. By targeting the detrimental effects of ischemia-reperfusion injury, which can lead to cell death, Cellvie's technology seeks to interrupt the cascade of cellular damage and enhance overall cell function.

Mogling Bio is a biotechnology firm focused on developing innovative pharmacological strategies to rejuvenate aging stem cells, particularly within the hematopoietic system. By targeting and inhibiting the heightened activity of Cdc42, the company aims to restore the function of old stem cells, which can lead to improved production of blood and immune cells. This approach has the potential to provide new treatment options for patients suffering from leukemia and other blood disorders, while also enhancing overall immune system strength.

Elastrin Therapeutics is a biotech startup focused on developing innovative therapies to restore hardened and damaged arteries and tissues. The company's proprietary technology targets elastic fibers, specifically aiming to reverse the degradation of elastin caused by harmful calcification that contributes to arterial stiffness. By combining advanced particle design with elastin-targeting mechanisms, Elastrin enhances the effectiveness of existing drugs while minimizing side effects. Their therapeutics address critical health issues related to arterial and lung diseases, providing healthcare professionals with promising treatment options for life-threatening conditions resulting from tissue damage and inflammation.

Revel Pharmaceuticals Inc. is a biotechnology company based in San Francisco, California, focused on developing therapeutic designer enzymes to address the molecular damage that accumulates with aging. Incorporated in 2019, the company is dedicated to creating treatments that degrade age-associated damage, particularly through its GlycoSENS therapeutic, which targets glucosepane crosslinks. This approach aims to maintain and restore the elasticity of blood vessels, skin, and other tissues, mitigating the effects of age-related stiffening. Revel's portfolio includes therapeutics for various age-related diseases, such as osteoarthritis, kidney disease, cardiovascular disease, skin aging, and complications of diabetes.

Underdog Pharmaceuticals, Inc. specializes in developing regenerative medicine and direct interventions aimed at treating age-related diseases. Founded in 2019 and headquartered in Mountain View, California, the company focuses on addressing the underlying causes of conditions such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration. It employs innovative approaches by targeting toxic forms of cholesterol using rationally designed molecules and novel derivatives of established safe compounds. The company aims to provide the first true disease-modifying treatments for these ailments, reflecting a new perspective on cardiovascular disease inspired by the SENS Research Foundation program.

Staffbase is a company that specializes in enhancing employee communication through its comprehensive Communications Cloud platform. The platform is designed for large and international organizations across various sectors, including manufacturing, healthcare, logistics, automotive, retail, and energy. It enables employers to securely engage with their workforce, ensuring that employees have easy access to relevant corporate information and digital workplace tools, including existing intranets. With a focus on mobile compatibility, Staffbase's solutions allow companies to effectively connect with their employees, regardless of their location, whether in the office, at home, or on the factory floor. Serving over 2,500 leading organizations worldwide, Staffbase is dedicated to transforming the way companies communicate with their employees.

Elastrin Therapeutics is a biotech startup focused on developing innovative therapies to restore hardened and damaged arteries and tissues. The company's proprietary technology targets elastic fibers, specifically aiming to reverse the degradation of elastin caused by harmful calcification that contributes to arterial stiffness. By combining advanced particle design with elastin-targeting mechanisms, Elastrin enhances the effectiveness of existing drugs while minimizing side effects. Their therapeutics address critical health issues related to arterial and lung diseases, providing healthcare professionals with promising treatment options for life-threatening conditions resulting from tissue damage and inflammation.

Cellvie specializes in the development of cell-derived medicines that focus on mitochondrial transplantation to address various medical conditions related to mitochondrial dysfunction. Recognizing the critical role of mitochondria in energy production and cellular processes, the company employs proprietary techniques to prepare and deliver viable mitochondria directly into compromised cells. This innovative approach aims to restore energy metabolism in cells affected by conditions such as heart disease, stroke, diabetes, Parkinson's, and Alzheimer's. By targeting the detrimental effects of ischemia-reperfusion injury, which can lead to cell death, Cellvie's technology seeks to interrupt the cascade of cellular damage and enhance overall cell function.

Elevian, Inc. is a biotechnology company based in Menlo Park, California, founded in 2017. The company focuses on developing medicines that aim to restore regenerative capacity and address age-related diseases. Elevian's research centers on the Growth Differentiation Factor 11 (GDF11) protein and other circulating blood factors that stimulate regeneration in various tissues, including the brain, heart, pancreas, and muscle. Its therapeutics are designed to target the underlying mechanisms of aging, with applications in stroke recovery, Alzheimer's disease, coronary artery disease, and Type 2 diabetes. Through its innovative approach, Elevian seeks to prevent and treat the effects of aging by enhancing the body's natural repair and regeneration processes.

Staffbase is a company that specializes in enhancing employee communication through its comprehensive Communications Cloud platform. The platform is designed for large and international organizations across various sectors, including manufacturing, healthcare, logistics, automotive, retail, and energy. It enables employers to securely engage with their workforce, ensuring that employees have easy access to relevant corporate information and digital workplace tools, including existing intranets. With a focus on mobile compatibility, Staffbase's solutions allow companies to effectively connect with their employees, regardless of their location, whether in the office, at home, or on the factory floor. Serving over 2,500 leading organizations worldwide, Staffbase is dedicated to transforming the way companies communicate with their employees.

Underdog Pharmaceuticals, Inc. specializes in developing regenerative medicine and direct interventions aimed at treating age-related diseases. Founded in 2019 and headquartered in Mountain View, California, the company focuses on addressing the underlying causes of conditions such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration. It employs innovative approaches by targeting toxic forms of cholesterol using rationally designed molecules and novel derivatives of established safe compounds. The company aims to provide the first true disease-modifying treatments for these ailments, reflecting a new perspective on cardiovascular disease inspired by the SENS Research Foundation program.

MAIA Biotechnology, Inc. is a clinical-stage biopharmaceutical company dedicated to developing targeted immunotherapies for cancer. The company focuses on creating potential first-in-class drugs with innovative mechanisms aimed at significantly improving and extending the lives of patients with cancer. Its lead program, THIO, is a novel cancer telomere-targeting agent currently in clinical development, specifically designed to treat telomerase-positive cancer cells. By concentrating on these advanced therapeutic approaches, MAIA Biotechnology seeks to make a meaningful impact in the field of oncology.

LIfT BioSciences is a biotechnology company based in London, England, founded in 2016. The company specializes in a novel allogeneic innate immuno-cell therapy platform known as Neutrophil Only Leukocyte Infusion Therapy (N-LIfT). This platform enables the large-scale production of Immunomodulatory Alpha Neutrophils (IMANs) derived from induced pluripotent stem cells (iPSCs) for various therapeutic applications. LIfT BioSciences focuses on developing CAR neutrophil cell therapies that address the limitations of existing treatments for solid tumors. These therapies work by directly attacking tumors and indirectly enhancing the immune response, effectively transforming the tumor microenvironment to recruit additional immune cells for a more robust and lasting attack on the cancer. By employing proprietary enhancement media and genetic engineering, LIfT BioSciences aims to significantly increase the cancer-fighting capabilities of these engineered cells, potentially providing patients with greatly improved therapeutic outcomes.

Staffbase is a company that specializes in enhancing employee communication through its comprehensive Communications Cloud platform. The platform is designed for large and international organizations across various sectors, including manufacturing, healthcare, logistics, automotive, retail, and energy. It enables employers to securely engage with their workforce, ensuring that employees have easy access to relevant corporate information and digital workplace tools, including existing intranets. With a focus on mobile compatibility, Staffbase's solutions allow companies to effectively connect with their employees, regardless of their location, whether in the office, at home, or on the factory floor. Serving over 2,500 leading organizations worldwide, Staffbase is dedicated to transforming the way companies communicate with their employees.

Turn.bio is a biotechnology company focused on developing drugs aimed at reversing aging and age-related diseases. Leveraging its patented mRNA platform technology, known as ERA, the company addresses the effects of aging on the epigenome, thereby restoring optimal gene expression. Turn.bio’s innovative approach enables the body to heal itself by instructing specific cells to combat diseases or repair damaged tissues. The company targets a range of medical indications, including immune-related diseases such as cancer, dermatological conditions, ophthalmology, osteoarthritis, and issues related to the muscular system. Through its advanced delivery platform, eTurna, Turn.bio seeks to enhance the effectiveness of nucleic acid therapeutics in promoting health and longevity.

MOQO is a cloud-based platform that enables various entities, including municipal utilities, the real estate sector, corporations, and organizations, to provide shared mobility services. The platform is designed to deliver a comprehensive package that facilitates the integration of mobility services, allowing clients to access an extensive shared mobility ecosystem. By focusing on quality and cost-effectiveness, MOQO aims to enhance the accessibility and efficiency of shared transportation solutions.

FoxBio is a developer of a small molecules techniques intended to reduce senescent cells in human bodies. The company's techniques targets the pro-survival pathways of senescent cells to remove them from the body, enabling patients to have multiple health benefits and delay the onset of age related diseases.

Staffbase is a company that specializes in enhancing employee communication through its comprehensive Communications Cloud platform. The platform is designed for large and international organizations across various sectors, including manufacturing, healthcare, logistics, automotive, retail, and energy. It enables employers to securely engage with their workforce, ensuring that employees have easy access to relevant corporate information and digital workplace tools, including existing intranets. With a focus on mobile compatibility, Staffbase's solutions allow companies to effectively connect with their employees, regardless of their location, whether in the office, at home, or on the factory floor. Serving over 2,500 leading organizations worldwide, Staffbase is dedicated to transforming the way companies communicate with their employees.

Elevian, Inc. is a biotechnology company based in Menlo Park, California, founded in 2017. The company focuses on developing medicines that aim to restore regenerative capacity and address age-related diseases. Elevian's research centers on the Growth Differentiation Factor 11 (GDF11) protein and other circulating blood factors that stimulate regeneration in various tissues, including the brain, heart, pancreas, and muscle. Its therapeutics are designed to target the underlying mechanisms of aging, with applications in stroke recovery, Alzheimer's disease, coronary artery disease, and Type 2 diabetes. Through its innovative approach, Elevian seeks to prevent and treat the effects of aging by enhancing the body's natural repair and regeneration processes.

shyftplan GmbH, based in Berlin, Germany, specializes in developing software solutions for the human resources sector. Founded in 2012, the company offers a comprehensive SaaS platform that facilitates employee management and communication. Its core functionality centers on shift scheduling, while also encompassing absence management, time tracking, working time accounts, HR management, and payroll services. The platform enables HR managers to create and manage shift plans, assigning employees to specific shifts based on their competencies. Additionally, shyftplan enhances workforce management by integrating employee intelligence and facilitating communication for non-desk workers, thus connecting them to their work environments and organizational frameworks.

Antoxerene, Inc. is an intellectual property holding company focused on small molecule drug discovery related to aging. Operating as an affiliate of Ichor Therapeutics, the company utilizes proprietary next-generation screening technology to identify small molecules that target protein-drug and protein-protein interactions. Its innovative platform is based on a patent-pending production technology that allows for the large-scale manufacturing of challenging protein targets in biologically active forms. Established in 2016 and headquartered in Lafayette, New York, Antoxerene aims to collaborate with industry and academic partners to develop next-generation therapies that address age-related illnesses. The company's research emphasizes the discovery of novel compounds that selectively eliminate toxic senescent cells, thereby restoring tissue function and enhancing patient outcomes.

AgeX Therapeutics is a biotechnology company dedicated to developing innovative therapeutics aimed at addressing human aging and degenerative diseases. Based in Alameda, California, the company focuses on harnessing proprietary technologies, such as telomerase-mediated cell immortality and induced Tissue Regeneration (iTR), to create treatments for age-related conditions. Its primary product pipeline includes two cell-based therapies: AGEX-BAT1, designed to treat age-related metabolic disorders like Type II diabetes, and AGEX-VASC1, which aims to restore vascular support in ischemic tissues. Additionally, AgeX is advancing AGEX-iTR1547, a drug-based formulation intended to enhance regenerative potential in aged tissues affected by degenerative diseases. The company also markets human embryonic stem cells and offers tools for genomic interpretation through the GeneCards Database Suite. AgeX Therapeutics collaborates with academic institutions, including a research program with the University of California, Irvine, focusing on neural stem cells for Huntington's disease and other neurological disorders. Founded in 2017, AgeX continues to explore novel solutions for aging-related challenges.

CellAge is a biotechnology company focused on developing innovative tools and therapies aimed at identifying and removing aged cells. By employing synthetic biology, CellAge creates methods to target and eliminate senescent cells, which have been linked to age-related diseases such as osteoarthritis and atherosclerosis. The company’s goal is to empower medical researchers to develop safe and effective gene therapies, ultimately contributing to a healthier and more active aging population. CellAge envisions a future where individuals can enjoy their later years with the same vigor and vitality as their younger years, free from the burdens of age-related health issues.

Lysoclear, Inc. is a biotechnology company based in Lafayette, New York, that focuses on developing enzyme therapies for eye diseases. Founded in 2016, the company is engaged in creating treatments for conditions such as age-related macular degeneration (AMD) and Stargardt’s macular degeneration. Lysoclear aims to address these diseases through innovative enzyme therapies, particularly targeting lysosomal storage disorders that arise from deficiencies in endogenous lysosomal enzymes. As a pre-clinical entity within the Ichor Therapeutics portfolio, Lysoclear is concentrated on advancing its therapeutic leads for atrophic "dry" AMD and other related conditions.

MOQO is a cloud-based platform that enables various entities, including municipal utilities, the real estate sector, corporations, and organizations, to provide shared mobility services. The platform is designed to deliver a comprehensive package that facilitates the integration of mobility services, allowing clients to access an extensive shared mobility ecosystem. By focusing on quality and cost-effectiveness, MOQO aims to enhance the accessibility and efficiency of shared transportation solutions.

Staffbase is a company that specializes in enhancing employee communication through its comprehensive Communications Cloud platform. The platform is designed for large and international organizations across various sectors, including manufacturing, healthcare, logistics, automotive, retail, and energy. It enables employers to securely engage with their workforce, ensuring that employees have easy access to relevant corporate information and digital workplace tools, including existing intranets. With a focus on mobile compatibility, Staffbase's solutions allow companies to effectively connect with their employees, regardless of their location, whether in the office, at home, or on the factory floor. Serving over 2,500 leading organizations worldwide, Staffbase is dedicated to transforming the way companies communicate with their employees.

Ichor Therapeutics, Inc. is a pre-clinical biotechnology company located in Syracuse, NY. The company has several intramural research programs that broadly focus on therapeutic interventions for age-related disease. Ichor is also involved in several smaller ventures aimed at reducing the barriers to entry for biotechnology entrepreneurs and independent scientists.

SuitePad GmbH, based in Berlin, Germany, specializes in tablet-based communication solutions for the hospitality industry. Founded in 2012, the company developed a digital guest communication platform that integrates various services into a single device, allowing guests to access essential hotel information and make bookings for room service, wellness appointments, and local attractions directly from their room. The SuitePad, designed with input from both private and chain hoteliers across Germany, Austria, and Switzerland, addresses the actual needs of the hospitality sector. Since its first installation in 2013, SuitePad has expanded its presence to 11 European countries and has received several industry accolades, including the CeBit BITKOM Innovation Award and the HSMAI Technology and Innovation Award.

Mambu is a leading provider of a cloud-based core banking platform that specializes in composable banking solutions. Founded over a decade ago, the company has pioneered the concept of composable banking, allowing financial institutions to combine independent systems and connectors to create customized banking solutions that adapt to evolving customer demands. With a presence in 60 countries, Mambu serves over 200 clients, including banks, lenders, fintech companies, and retailers, enabling them to develop and deploy modern digital financial products efficiently and securely. The platform supports the creation, launch, and servicing of various loan and deposit products, providing a flexible architecture that empowers financial institutions, including microfinance organizations, to effectively address market opportunities and deliver essential banking services.

Staffbase is a company that specializes in enhancing employee communication through its comprehensive Communications Cloud platform. The platform is designed for large and international organizations across various sectors, including manufacturing, healthcare, logistics, automotive, retail, and energy. It enables employers to securely engage with their workforce, ensuring that employees have easy access to relevant corporate information and digital workplace tools, including existing intranets. With a focus on mobile compatibility, Staffbase's solutions allow companies to effectively connect with their employees, regardless of their location, whether in the office, at home, or on the factory floor. Serving over 2,500 leading organizations worldwide, Staffbase is dedicated to transforming the way companies communicate with their employees.

Prescreen GmbH is a Munich-based company that develops and operates a cloud-based e-recruitment platform and applicant tracking system. Founded in 2011, Prescreen allows organizations to publish job vacancies both online and offline, facilitating direct applications from candidates. The platform efficiently collects and analyzes applications, streamlining the evaluation process for employers and enhancing overall recruitment efficiency. As of July 2017, Prescreen has been a subsidiary of XING AG, further integrating its services within a broader professional networking context.

Oisin Biotechnologies is a biotechnology company based in Seattle, Washington, that specializes in developing therapies to address age-related diseases by targeting senescent cells. Founded in 2014, the company focuses on its SENSOlytics platform, which employs a precise, patent-pending approach to selectively clear these cells using DNA expression markers. This innovative strategy aims to mitigate the adverse effects of aging and has been shown to extend lifespan and improve health outcomes. Oisin's lead program is designed to combat frailty by promoting muscle growth without the need for exercise, while additional programs target fat cell reduction and other age-related conditions. The company utilizes a novel non-viral delivery system that ensures effective distribution of both DNA and RNA therapeutics, positioning Oisin Biotechnologies as a leader in rejuvenation biotechnology.

shyftplan GmbH, based in Berlin, Germany, specializes in developing software solutions for the human resources sector. Founded in 2012, the company offers a comprehensive SaaS platform that facilitates employee management and communication. Its core functionality centers on shift scheduling, while also encompassing absence management, time tracking, working time accounts, HR management, and payroll services. The platform enables HR managers to create and manage shift plans, assigning employees to specific shifts based on their competencies. Additionally, shyftplan enhances workforce management by integrating employee intelligence and facilitating communication for non-desk workers, thus connecting them to their work environments and organizational frameworks.

Mambu is a leading provider of a cloud-based core banking platform that specializes in composable banking solutions. Founded over a decade ago, the company has pioneered the concept of composable banking, allowing financial institutions to combine independent systems and connectors to create customized banking solutions that adapt to evolving customer demands. With a presence in 60 countries, Mambu serves over 200 clients, including banks, lenders, fintech companies, and retailers, enabling them to develop and deploy modern digital financial products efficiently and securely. The platform supports the creation, launch, and servicing of various loan and deposit products, providing a flexible architecture that empowers financial institutions, including microfinance organizations, to effectively address market opportunities and deliver essential banking services.

SuitePad GmbH, based in Berlin, Germany, specializes in tablet-based communication solutions for the hospitality industry. Founded in 2012, the company developed a digital guest communication platform that integrates various services into a single device, allowing guests to access essential hotel information and make bookings for room service, wellness appointments, and local attractions directly from their room. The SuitePad, designed with input from both private and chain hoteliers across Germany, Austria, and Switzerland, addresses the actual needs of the hospitality sector. Since its first installation in 2013, SuitePad has expanded its presence to 11 European countries and has received several industry accolades, including the CeBit BITKOM Innovation Award and the HSMAI Technology and Innovation Award.

Babbel is a language learning company dedicated to fostering mutual understanding through communication across cultures. It offers an ecosystem of online language learning experiences, including the Babbel App, Babbel Live, podcasts, and Babbel for Business. The platform features over 60,000 lessons in 14 languages, crafted by nearly 200 linguists and language experts, ensuring that the content is both engaging and effective. Learners can study at their own pace, participate in live online classes with expert teachers, and benefit from interactive content that includes games, podcasts, and videos. Babbel's approach is backed by studies from reputable institutions, confirming the effectiveness of its methods. With a diverse team of approximately 1,000 employees representing over 80 nationalities, Babbel operates from its headquarters in Berlin and a U.S. office in New York. The company has successfully sold over 16 million subscriptions by creating meaningful connections with its users, making language learning accessible anytime and anywhere across various devices.

Mambu is a leading provider of a cloud-based core banking platform that specializes in composable banking solutions. Founded over a decade ago, the company has pioneered the concept of composable banking, allowing financial institutions to combine independent systems and connectors to create customized banking solutions that adapt to evolving customer demands. With a presence in 60 countries, Mambu serves over 200 clients, including banks, lenders, fintech companies, and retailers, enabling them to develop and deploy modern digital financial products efficiently and securely. The platform supports the creation, launch, and servicing of various loan and deposit products, providing a flexible architecture that empowers financial institutions, including microfinance organizations, to effectively address market opportunities and deliver essential banking services.

Hipaway is an online platform that facilitates hotel bookings and reservations in Germany. The service allows users to easily search for and secure accommodations, streamlining the process of finding suitable lodging in various locations across the country. By focusing on the German market, Hipaway aims to enhance travelers' experiences by providing a convenient and user-friendly interface for hotel reservations.

Hojoki is a team collaboration application that integrates various cloud services to streamline workflow and communication. It enables users to consolidate notifications from multiple platforms, allowing for real-time discussion and updates related to ongoing projects. The application supports a wide range of cloud tools, including Google Docs, Dropbox, Evernote, and GitHub, among others. By bringing together these disparate applications, Hojoki enhances productivity and facilitates seamless teamwork.

Hojoki is a team collaboration application that integrates various cloud services to streamline workflow and communication. It enables users to consolidate notifications from multiple platforms, allowing for real-time discussion and updates related to ongoing projects. The application supports a wide range of cloud tools, including Google Docs, Dropbox, Evernote, and GitHub, among others. By bringing together these disparate applications, Hojoki enhances productivity and facilitates seamless teamwork.

Tamyca GmbH operates a peer-to-peer car-sharing marketplace that connects car owners with individuals looking to rent vehicles. Launched in Germany in November 2010, Tamyca allows car owners to list their idle vehicles, set prices, and specify availability, enabling them to earn extra income. Users can easily find available cars in their vicinity through a smartphone app or web service, typically saving up to 60% compared to conventional car-sharing and rental options. Tamyca also provides additional services, including anti-theft insurance, payment processing, and a rating system for enhanced user experience. The company continues to develop mobility solutions for original equipment manufacturers, car dealerships, and corporate clients.

Pactas provides a SaaS platform for recurring billing and subscription management for SaaS and subscription companies, no matter you are a startup or a well established business. Follow us: @pactashq on Twitter | pactas on Facebook

Advertory GmbH, founded in 2010 in Berlin by a German-French team, offers an online marketing platform tailored for small and mid-sized businesses. The platform provides various tools that enable users to create and maintain their online presence, integrated with local search capabilities and a mobile version aimed at attracting new customers in local markets. Advertory serves a diverse clientele, including freelancers, service providers, craftsmen, and restaurants, helping them become competitive in the digital landscape. The company's focus is on customer acquisition and retention, allowing small businesses to easily find new clients and cultivate loyalty. Advertory's solutions are designed to require minimal time investment from users, with features that operate automatically whenever possible, making the platform both efficient and effective for its users.

MegaZebra GmbH is a developer and publisher of casual online games, based in Munich, Germany. Founded in 2008, the company focuses on creating engaging games for social network communities. Its portfolio includes popular titles such as Solitaire Castle, Mahjong Trails, Mahjong, Nuzzle Puzzle, and Sudoku. MegaZebra's games are designed for integration with social networks, allowing players to connect and play with friends and family across various platforms. The company has a seasoned team of professionals, including Henning Kosmack, Steffen Rusitschka, Christian Meister, and Mark Gazecki, and received initial financing from KIZOO Technology Ventures in September 2009.

Mambu is a leading provider of a cloud-based core banking platform that specializes in composable banking solutions. Founded over a decade ago, the company has pioneered the concept of composable banking, allowing financial institutions to combine independent systems and connectors to create customized banking solutions that adapt to evolving customer demands. With a presence in 60 countries, Mambu serves over 200 clients, including banks, lenders, fintech companies, and retailers, enabling them to develop and deploy modern digital financial products efficiently and securely. The platform supports the creation, launch, and servicing of various loan and deposit products, providing a flexible architecture that empowers financial institutions, including microfinance organizations, to effectively address market opportunities and deliver essential banking services.

MegaZebra GmbH is a developer and publisher of casual online games, based in Munich, Germany. Founded in 2008, the company focuses on creating engaging games for social network communities. Its portfolio includes popular titles such as Solitaire Castle, Mahjong Trails, Mahjong, Nuzzle Puzzle, and Sudoku. MegaZebra's games are designed for integration with social networks, allowing players to connect and play with friends and family across various platforms. The company has a seasoned team of professionals, including Henning Kosmack, Steffen Rusitschka, Christian Meister, and Mark Gazecki, and received initial financing from KIZOO Technology Ventures in September 2009.

Babbel is a language learning company dedicated to fostering mutual understanding through communication across cultures. It offers an ecosystem of online language learning experiences, including the Babbel App, Babbel Live, podcasts, and Babbel for Business. The platform features over 60,000 lessons in 14 languages, crafted by nearly 200 linguists and language experts, ensuring that the content is both engaging and effective. Learners can study at their own pace, participate in live online classes with expert teachers, and benefit from interactive content that includes games, podcasts, and videos. Babbel's approach is backed by studies from reputable institutions, confirming the effectiveness of its methods. With a diverse team of approximately 1,000 employees representing over 80 nationalities, Babbel operates from its headquarters in Berlin and a U.S. office in New York. The company has successfully sold over 16 million subscriptions by creating meaningful connections with its users, making language learning accessible anytime and anywhere across various devices.